Form 8-K - Current report:
SEC Accession No. 0000939767-21-000028
Filing Date
2021-03-03
Accepted
2021-03-03 16:34:25
Documents
16
Period of Report
2021-02-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20210225.htm   iXBRL 8-K 40057
2 EX-3.1 exhibit31amendedandrestate.htm EX-3.1 192853
8 exel-20210225_g1.jpg GRAPHIC 116418
  Complete submission text file 0000939767-21-000028.txt   671874

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20210225.xsd EX-101.SCH 2436
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT exel-20210225_cal.xml EX-101.CAL 722
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT exel-20210225_def.xml EX-101.DEF 1659
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20210225_lab.xml EX-101.LAB 25282
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20210225_pre.xml EX-101.PRE 13199
9 EXTRACTED XBRL INSTANCE DOCUMENT exel-20210225_htm.xml XML 11636
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 21709520
SIC: 2836 Biological Products, (No Diagnostic Substances)